These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30420214)

  • 1. Hybrid Imaging (PET-Computed Tomography/PET-MR Imaging) of Bone Metastases.
    Schmidkonz C; Ellmann S; Ritt P; Roemer FW; Guermazi A; Uder M; Kuwert T; Bäuerle T
    PET Clin; 2019 Jan; 14(1):121-133. PubMed ID: 30420214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
    Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
    Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
    Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
    Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of PET-Computed Tomography-Magnetic Resonance in the Management of Benign Musculoskeletal Disorders.
    Yoder JS; Kogan F; Gold GE
    PET Clin; 2019 Jan; 14(1):1-15. PubMed ID: 30420212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies.
    Behzadi AH; Raza SI; Carrino JA; Kosmas C; Gholamrezanezhad A; Basques K; Matcuk GR; Patel J; Jadvar H
    PET Clin; 2018 Oct; 13(4):623-634. PubMed ID: 30219192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future Perspective of the Application of Positron Emission Tomography-Computed Tomography-MR Imaging in Musculoskeletal Disorders.
    Angelini A; Castellucci P; Ceci F
    PET Clin; 2019 Jan; 14(1):183-191. PubMed ID: 30420219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications.
    Parghane RV; Basu S
    PET Clin; 2018 Oct; 13(4):459-476. PubMed ID: 30219182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Choice of the imaging technique for the diagnosis of bone metastases].
    Genovese EA; Mallardo V; Rosati I; Prisco MR; Fontanarosa A; Della Vecchia N; D'Agosto G; Santagata M; Basile A
    Recenti Prog Med; 2013; 104(7-8):361-6. PubMed ID: 24042408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of Osteoarthritis by Conventional Radiography, MR Imaging, PET-Computed Tomography, and PET-MR Imaging.
    Hayashi D; Roemer FW; Guermazi A
    PET Clin; 2019 Jan; 14(1):17-29. PubMed ID: 30420217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis.
    Duo J; Han X; Zhang L; Wang G; Ma Y; Yang Y
    Clin Nucl Med; 2013 May; 38(5):343-8. PubMed ID: 23531774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
    Samarin A; Hüllner M; Queiroz MA; Stolzmann P; Burger IA; von Schulthess G; Veit-Haibach P
    Nucl Med Commun; 2015 Dec; 36(12):1165-73. PubMed ID: 26397999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MRI vs PET/CT in Head and Neck Imaging: When, Why, and How?
    Ryan JL; Aaron VD; Sims JB
    Semin Ultrasound CT MR; 2019 Oct; 40(5):376-390. PubMed ID: 31635765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Gastrointestinal Tract Applications of PET/Computed Tomography and PET/MR Imaging.
    Catalano O; Kilcoyne A; Signore A; Mahmood U; Rosen B
    Radiol Clin North Am; 2018 Sep; 56(5):821-834. PubMed ID: 30119776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.